Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP): A Randomized Controlled Trial

NCT06804096 is registered in ClinicalTrials.gov with Dr. Md. Alimur Reza as lead sponsor.

NCT NCT06804096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06804096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP): A Randomized Controlled Trial
Lead sponsor
Dr. Md. Alimur Reza
Phase
Phase 4
Overall status
Completed
Start date
February 20, 2025
Completion date
January 26, 2026
Enrollment
129 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial pneumonia, pneumonia, community-acquired